Modulation of T-regulatory cells by small molecules: potential therapy for GvHD
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is often curative for patients suffering from blood cancers. Nonetheless, significant morbidity and mortality are still prevalent. One major complication is graft versus host disease (GvHD) which occurs in 30-70% of patients. In this dis...
المؤلف الرئيسي: | Leuschner, U |
---|---|
مؤلفون آخرون: | Roberts, D |
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
2021
|
مواد مشابهة
-
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
حسب: Mauro Di Ianni, وآخرون
منشور في: (2024-01-01) -
The Role of Bacteria and Pattern Recognition Receptors in GvHD
حسب: E. Holler, وآخرون
منشور في: (2010-01-01) -
Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells
حسب: Haroon Shaikh, وآخرون
منشور في: (2022-11-01) -
Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
حسب: Martin eSzyska, وآخرون
منشور في: (2016-03-01) -
Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
حسب: Kudakwashe Mhandire, وآخرون
منشور في: (2021-10-01)